What's New in Prostate

Insights from 2024 ASCO® GU Annual Meeting
B

ASCO® GU 2024 Insights: "Impact of Standard-of-Truth Method on Evaluation of a Diagnostic PET Radiopharmaceutical in Prostate Cancer - Learnings From the SPOTLIGHT Study"

By Insights from 2024 ASCO® GU Annual Meeting FEATURING Benjamin Lowentritt
By Insights from 2024 ASCO® GU Annual Meeting FEATURING Benjamin Lowentritt
72 views
February 1, 2024
Comments 0
Login to view comments. Click here to Login
05:59

The Role of CDK4/6 Inhibitors in Metastatic Prostate Cancer

Ulka Vaishampayan

85 views
11:56

Liquid Biopsy as a Treatment Selector in mCRPC

PROSCA & BLADDR 2023

B. De Laere

52 views
14:45

QoL in Patients With Advanced Prostate Cancer Who Are Living Longer:…

PROSCA & BLADDR 2023

D. Raggi

61 views
12:27

Clinical Implications of Genomic Alterations in Prostate Cancer

PROSCA & BLADDR 2023

D. Olmos

125 views
16:55

Intermediate to High-Risk Prostate Cancer: Who Needs Treatment Inten…

PROSCA & BLADDR 2023

P. Ost

111 views
07:43

Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: Th…

Andrew Hahn

341 views
10:13

Treatment Intensification in Advanced Prostate Cancer

Judd Moul

448 views
21:57

Today Biomarkers and Targets in GU Cancers

International Urology Cancer Summit - IUCS

P. Rescigno

232 views
12:19

UNC Prostate Cancer Screening Updates

UNC Lineberger Comprehensive Cancer Center

H. Tan

308 views